HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

Menu

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
My View
Tags:
Consumer

CHATTEM's CHARLES JOLLY ANNOUNCES BID FOR CONGRESS

This article was originally published in The Rose Sheet

  • News
  • The Rose Sheet

Executive Summary

CHATTEM's CHARLES JOLLY ANNOUNCES BID FOR CONGRESS to represent Tennessee's third congressional district. Jolly, currently VP, secretary and general counsel for Chattanooga, TN- based Chattem, announced Jan. 9 that he will seek the congressional seat held by Rep. Marilyn Lloyd (D), who will retire at the conclusion of the 103rd Congress. A Democrat, Jolly is a veteran of the OTC drug industry. He has been with Chattem since 1977 and spent the previous seven years at Miles Labs.

Table

View full table

Topics

Tags:
Consumer
Latest Headlines

Walmart Lays Out Expectations For Beauty Brands' MoCRA Compliance

US Consumer Health Market People News: Herbalife, Seed Health, Electrolit, Atlas Bars, More

US Women’s Health Sector: Hip Hop Stars Invest In Proov, Good Clean Love Names CEO

Reckitt Sees R&D Investment Translate To Volume Growth

See All
UsernamePublicRestriction

Register

RS000031

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By